Financial Results

Cardinal Systems was initially developed in 1996 since when it has continually reinvested profits generated back into the company. This strategy has resulted in increased development, which can clearly be seen in the growth of the company's turnover.

This development is complemented with core company principles, such as quality.

The company has been able to continue its planned expansion through successful exploration of new sources for funding. Which has most recently been obtained thanks to Anvar-BDPME(Oseo).

Turn Over (in K€)

1996: 224	2006: 2426
1997: 285	2007: 2576
1998: 435	2008: 3170
1999: 603	2009: 4250
2000: 724
2001: 898
2002: 1051
2003: 1071
2004: 1113
2005: 1499

Document Actions

Partners & Working Groups

Cardinal Systems works in partnership with O4CP for the Loulla & Philla FP7 project.

Cardinal Systems participates actively in working groups, such as DIA, PSI, CDISC, SFdS and EFSPI.

Cardinal Systems has been supporting France Biotech since 2001, and works closely with governmental institutions implicated in the valorisation of innovation, such as Oseo, Pactepme and Medicen.

Partners